Literature DB >> 33129812

Central Visual Field Defects in Patients with Distinct Glaucomatous Optic Disc Phenotypes.

Eren Ekici1, Sasan Moghimi2, Huiyuan Hou2, James Proudfoot2, Linda M Zangwill2, Jiun L Do2, Won Hyuk Oh3, Alireza Kamalipour2, Jeffrey M Liebmann4, Carlos Gustavo De Moraes4, Christopher A Girkin5, Nevin El-Nimri2, Robert N Weinreb6.   

Abstract

PURPOSE: To investigate central visual field (VF) defects among 4 phenotypes of glaucomatous optic discs.
DESIGN: Cross-sectional study.
METHODS: Optic disc phenotypes were determined in eyes with definite or suspected glaucoma that had a 24-2 VF with mean deviation (MD) better than -12 dB and a 10-2 VF. 10-2 VFs were classified as abnormal based on a cluster criterion. Additionally, the average of the total deviation values at each 10-2 test point was compared by optic disc phenotype.
RESULTS: The following 4 glaucomatous optic disc phenotypes were identified in 448 eyes of 309 patients: focal ischemic (FI) (n = 121); generalized cup enlargement (GE) (n = 109); myopic glaucoma (MY) (n = 66); and senile sclerotic (SS) (n = 152). Although 24-2 VF MD values were similar among optic disc phenotypes, GE eyes had higher 10-2 VF MD (P = .004), as well as lower 24-2 VF pattern standard deviations (PSD) (P < .001) and VF 10-2 PSD (P < .001) than the other phenotypes. The prevalence of an abnormal VF 10-2 was highest in FI eyes (78.5%) and lowest in GE eyes (50.5%) (P < .001). In glaucoma suspects, the prevalence of an abnormal 10-2 VF was highest in the MY eyes (31.2%) and FI eyes (23.5%) and lowest in GE eyes (8.6%). In mild glaucoma, the prevalence of abnormal 10-2 VF test results was highest in FI eyes (79.2%) and lowest in GE eyes (44.4%) (P = .013).
CONCLUSIONS: The severity and prevalence of central VF loss varied among different glaucomatous optic disc phenotypes. Glaucomatous eyes with FI and MY optic disc phenotypes are more likely to have 10-2 VF loss, particularly in early disease, and especially may benefit from testing with both 10-2 and 24-2 VF tests.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33129812      PMCID: PMC7979468          DOI: 10.1016/j.ajo.2020.10.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  31 in total

Review 1.  Blood flow in the optic nerve head and factors that may influence it.

Authors:  S S Hayreh
Journal:  Prog Retin Eye Res       Date:  2001-09       Impact factor: 21.198

2.  Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma.

Authors:  Neville N Osborne
Journal:  Exp Eye Res       Date:  2010-03-30       Impact factor: 3.467

3.  Baseline 24-2 Central Visual Field Damage Is Predictive of Global Progressive Field Loss.

Authors:  Aakriti Garg; C Gustavo De Moraes; George A Cioffi; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill; Jeffrey M Liebmann
Journal:  Am J Ophthalmol       Date:  2018-01-06       Impact factor: 5.258

4.  Lack of diffuse loss of differential light sensitivity in early glaucoma.

Authors:  A Heijl
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-08

5.  Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma.

Authors:  Zhichao Wu; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2018-08-10       Impact factor: 5.258

6.  Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics.

Authors:  Sung Chul Park; Carlos Gustavo De Moraes; Christopher C W Teng; Celso Tello; Jeffrey M Liebmann; Robert Ritch
Journal:  Ophthalmology       Date:  2011-06-12       Impact factor: 12.079

7.  Four Questions for Every Clinician Diagnosing and Monitoring Glaucoma.

Authors:  Donald C Hood; Carlos G De Moraes
Journal:  J Glaucoma       Date:  2018-08       Impact factor: 2.503

8.  Association Between Undetected 10-2 Visual Field Damage and Vision-Related Quality of Life in Patients With Glaucoma.

Authors:  Dana M Blumberg; Carlos Gustavo De Moraes; Alisa J Prager; Qi Yu; Lama Al-Aswad; George A Cioffi; Jeffrey M Liebmann; Donald C Hood
Journal:  JAMA Ophthalmol       Date:  2017-07-01       Impact factor: 7.389

Review 9.  Mechanisms of optic nerve damage in primary open angle glaucoma.

Authors:  R D Fechtner; R N Weinreb
Journal:  Surv Ophthalmol       Date:  1994 Jul-Aug       Impact factor: 6.048

10.  Classification of visual field abnormalities in the ocular hypertension treatment study.

Authors:  John L Keltner; Chris A Johnson; Kimberly E Cello; Mary A Edwards; Shannan E Bandermann; Michael A Kass; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2003-05
View more
  2 in total

1.  Macular Optical Coherence Tomography Imaging in Glaucoma.

Authors:  Alireza Kamalipour; Sasan Moghimi
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

2.  Incidence of Dementia in Patients With Open-angle Glaucoma: A Population-based Study.

Authors:  Aditya V Belamkar; Sasha A Mansukhani; Rodolfo Savica; Matthew R Spiegel; David O Hodge; Arthur J Sit
Journal:  J Glaucoma       Date:  2021-03-01       Impact factor: 2.290

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.